• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    MPO's Most-Read Stories This Week—Jan. 28

    Alleviant Medical Closes $75M Financing Round

    Know Labs Founder Ron Erickson Named CEO

    Getinge's Recall of Cardiosave Hybrid and Rescue IABPs is Class I

    FDA OKs Tidepool Loop App Connecting CGMs, Insulin Pumps
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Reflections on 2022 and What’s Ahead for Medtech: MPO Sounding Board

    3 Ways to Prepare for ISO 13485/Part 820 Harmonization

    A New Home for Theranos' Elizabeth Holmes?

    Health Cost Drivers for Large Employers

    Braving Change: Facing Fears in the Midst of Major Transitions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Medbio LLC

    Providence Enterprise USA Inc.

    JBC Technologies

    Arthur G. Russell Co. Inc., The

    NDH Medical Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing

    Telemedicine and Connectivity to Drive Material Innovation in the Near Future
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Medbio LLC

    Providence Enterprise USA Inc.

    JBC Technologies

    Arthur G. Russell Co. Inc., The

    NDH Medical Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Jason Luke Joins physIQ's Medical Advisory Board

    Luke is director of the Immunotherapy and Drug Development Center at the University of Pittsburgh Medical Center Hillman Cancer Center.

    Michael Barbella, Managing Editor11.28.22
    physIQ has appointed Jason Luke, M.D., FACP, to the company’s Medical Advisory Board. In this role, Luke will provide expert medical counsel for physIQ’s ongoing development of solutions to aide in oncology treatments, including physIQ’s development of digital biomarkers for inflammation.
     
    “Dr. Luke brings extensive immuno-oncology expertise to physIQ that will provide immeasurable insight into our work on inflammation and oncology treatments,” physIQ Chief Medical Officer Steve Steinhubl, M.D., said. “As a practicing physician and researcher, he brings the vision, experience, and empathy that we embrace at physIQ.”
     
    One of Luke’s first projects with physIQ is to serve as principal investigator on a clinical study designed to show how the company’s Inflammatory Multivariate Change Index (iMCI) can make CAR-T, a ground-breaking oncology treatment, safer and more accessible by enabling real-time in-home safety monitoring post CAR-T dosing. Luke is director of the Immunotherapy and Drug Development Center at the University of Pittsburgh Medical Center Hillman Cancer Center and associate professor at the University of Pittsburgh. He focuses on translational therapeutic advances in immuno-oncology, early phase drug development for advanced solid tumors and the management of patients with cutaneous malignancies.
     
    In melanoma, Luke has designed and led two practice-changing studies documenting the role of combination anti-PD1 + low dose anti-CTLA4 Ab in PD1 refractory disease, as well as establishing the role for, and U.S. Food and Drug Administration/EMA approval of, adjuvant anti-PD1 for stage IIB/C melanoma. More generally, Luke has been a lead investigator for clinical trials of many novel immunotherapies in advanced solid tumors. He has been a major contributor toward the investigation of radiation and the microbiome in relation to cancer immunotherapy.
     
    Luke’s translational research laboratory focuses on biomedical and bioinformatic approaches to advance cancer immunotherapy. He is an at-large member of the Society for Immunotherapy of Cancer Board of Directors and has held leadership roles in SMR, American Association for Cancer Rresearch, and American Society of Clinical Oncology. Luke is the PI or project leader for multiple funding mechanisms including R01, UM1, P50 and multiple state or private grants.
     
    Luke earned his medical degree from Rosalind Franklin University of Medicine and Science/Chicago Medical School in North Chicago. He completed an internship and residency in internal medicine at Boston University Medical Center and fellowships in medicine and medical oncology at Weill Cornell Medical Center and Memorial Sloan-Kettering Cancer Center in New York City.
     
    physIQ delivers personalized medical predictions that vastly improve patient outcomes. By combining proprietary AI and any wearable biosensor to continuously monitor patients in real-world settings, physIQ advances medicine and enables clinical trial sponsors and clinicians to proactively detect physiological decompensations, improve the safety and efficacy of new therapies and speed time to market, and deliver personalized clinical interventions to improve patient outcomes. 

      Loading, Please Wait..

      Trending
      • Study: Catheter Ablation Significantly Lowers Dementia Risk In AFib Patients
      • Promising Study Results Released For Uncontrolled Hypertension Treatment
      • Abbott's Proclaim XR SCS OK'ed For Diabetic Neuropathy
      • BMP Medical Expands Sterling, Massachusetts Facility
      • FDA OKs Tidepool Loop App Connecting CGMs, Insulin Pumps
      Breaking News
      • MPO's Most-Read Stories This Week—Jan. 28
      • Alleviant Medical Closes $75M Financing Round
      • Know Labs Founder Ron Erickson Named CEO
      • Getinge's Recall of Cardiosave Hybrid and Rescue IABPs is Class I
      • FDA OKs Tidepool Loop App Connecting CGMs, Insulin Pumps
      View Breaking News >
      CURRENT ISSUE

      November 2022

      • MPO's 2022 Year in Review
      • Fine Print: A Discourse on Additive Manufacturing
      • Grab and Go: Examining the Thrombectomy Device Market
      • View More >

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Nutrasource Rebrands Clinical Trial Site to Apex Trials
      Kerry Sponsors Upcycled Food Foundation Research Fellowship
      Probiotics Supplementation Reduces Complications in Colorectal Cancer Patients
      Coatings World

      Latest Breaking News From Coatings World

      Epoxytec Announces New Website Launch
      Paints and Coatings Market Worth $212B by 2026: MarketsandMarkets
      Axalta Releases Fourth Quarter and Full Year 2022 Results
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      MPO's Most-Read Stories This Week—Jan. 28
      Alleviant Medical Closes $75M Financing Round
      Know Labs Founder Ron Erickson Named CEO
      Contract Pharma

      Latest Breaking News From Contract Pharma

      SK bioscience Introduces New Global Partnership Model for Vaccines
      Merck's KEYTRUDA Wins Expanded Approval in Non-Small Cell Lung Cancer
      Bone Biologics Engages Avania for NB1 Clinical Trial
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      LVMH Reports Record 2022
      Haircare Brand Uncle Funky’s Daughter Announces Retail Expansion
      TRESemmé Introduces New Pro Infusion Collection
      Happi

      Latest Breaking News From Happi

      Alix Earle, Jonathan Monroe Are Fast-Growing Beauty Influencers on Instagram
      Fragrance Creators Launches First-of-its-Kind Data Insights Program
      The Lip Bar Enters the Skin Care Category with First-Ever Skincare Collection
      Ink World

      Latest Breaking News From Ink World

      Weekly Recap: Sustainability and Pigments, TSCA and Raw Materials Top This Week’s Stories
      Roland DGA Announces Major Expansion of TrueVIS Printer Family
      Neos Expands Production Capacity, European Market Presence
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Channeled Resources launches blank labels with PET liner
      Infigo partners with Four Pees in Benelux region
      EFI appoints Frank Pennisi CEO, Fiery now an independent business
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Essity’s Sales Grow
      Thinx to Pay up to $5 million to Settle Class Action Suit
      Typar Highlighting New Building Innovations
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      ODT's Most-Read Stories This Week—Jan. 28
      Roche, Sysnav Partner on Movement Tracking Tech for Neuromuscular Disorders
      Orthopedic Braces/Support, Casting/Splints Market to Top $12B by 2030
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Weekly Recap: Avery Dennison, CES 2023 and Canatu’s LiDAR Deicing Top This Week’s Stories
      Celanese Launches Nine New Conductive Inks
      NREL Develops Thin, Lightweight Layer for Radiation Barrier for Perovskites in Space

      Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login